Retail pharmacy market increased by 8.5% and amounted to 603 billion rubles for 1-3 quarter in Russia.
The concentration in TOP 15 leading pharmacy chains is growing and takes 24.6% as a result of 1-3 quarters. Also it should be mentioned that this figure is increasing from one quarter to another (the share of TOP-15 pharmacy chains is about 25.4% in Q3). Thus, the share of leading pharmacy chains will reach about 25% (while this indicator was registered at the level of 21%).
The largest turnover growth among TOP-15 was represented by two pharmacy chains Pharmland and Samson-Pharma (32%) in comparison with Q3 2013. Only Pharmaimpex showed a turnover reduction by 3%.
The reason of this increase of concentration indicator was related to mergers of several large pharmacy chains in 2013. This trend was over in 2014.
In August 2014, "A5" and "Pharmaimpex" signed a contract on creating marketing partnership under own brand name "Kompas". It will give an opportunity to conduct mutual activities with drug manufacturers, to get the best terms & conditions of direct contracts and also it will enable to make unified products portfolio under own trade name. It was afterwards found out that A5» started negotiation with Pharmaimpex» about merging. The combined chain will become the leader in the market.
Finnish pharmaceutical company Oriola-KD consider selling its assets in Russia, which include "Stariylekar" and "03" pharmacies. Prospective customer is pharmacy chain "A.V.E.Group".
Thus, changes in the pharmacy retail goes on and on. Probably, the current disposition of forces will be changed again.
|
Ranking |
Pharmacy Chains |
Volume, billions of rubles |
Share of the Commercial segment, |
Turnover increase compared to |
Number of stores |
|
Q3 2014 |
Q3 2013 | ||||
|
1 |
Rigla |
6,6 |
3,3% |
23% |
1 122 |
|
2 |
Implozia |
5,9 |
2,9% |
15% |
1 100 |
|
3 |
A.V.E (with "36,6" is included) |
5,5 |
2,7% |
1% |
612 |
|
4 |
A5 |
4,7 |
2,3% |
20% |
992 |
|
5 |
Doctor Stoletov ( Ozerki is included) |
4,5 |
2,2% |
19% |
345 |
|
6 |
Raduga (Pervaya Pomosch is included) |
4,5 |
2,2% |
10% |
794 |
|
7 |
Pharmacor |
3,3 |
1,6% |
9% |
400 |
|
8 |
Pharmaimpex |
2,7 |
1,3% |
-3% |
524 |
|
9 |
Pharmland |
2,6 |
1,3% |
32% |
470 |
|
10 |
Planeta zdorovya |
2,2 |
1,1% |
5% |
530 |
|
11 |
Vita |
2,0 |
1,0% |
7% |
475 |
|
12 |
Klassika |
1,9 |
0,9% |
12% |
172 |
|
13 |
Samson-Pharma |
1,7 |
0,9% |
32% |
37 |
|
14 |
Ladushka |
1,7 |
0,8% |
10% |
225 |
|
15 |
Melodia zdorovya |
1,5 |
0,7% |
17% |
488 |
|
|
TOP-15 |
51,2 |
25,4% |
13,3% |
8 133 |
|
Ranking |
Pharmacy Chains |
Volume, billions of rubles |
Share of the Commercial segment, |
Turnover increase compared to |
Number of stores |
|
Q1-Q3 2014 |
Q1-Q3 2013 | ||||
|
1 |
Rigla |
19,2 |
3,2% |
19% |
1 122 |
|
2 |
A.V.E (with 36,6» is included) |
17,3 |
2,9% |
9% |
612 |
|
3 |
Implozia |
16,4 |
2,7% |
13% |
1 100 |
|
4 |
A5 |
14,0 |
2,3% |
16% |
992 |
|
5 |
Doctor Stoletov ( Ozerki is included) |
13,4 |
2,2% |
12% |
345 |
|
6 |
Raduga (Pervaya Pomosch is included) |
11,8 |
2,0% |
8% |
794 |
|
7 |
Pharmaimpex |
8,9 |
1,5% |
7% |
524 |
|
8 |
Planeta zdorovya |
7,3 |
1,2% |
9% |
530 |
|
9 |
Pharmland |
7,0 |
1,2% |
40% |
470 |
|
10 |
Pharmacor |
6,8 |
1,1% |
12% |
400 |
|
11 |
Klassika |
5,9 |
1,0% |
13% |
172 |
|
12 |
Vita |
5,9 |
1,0% |
6% |
475 |
|
13 |
Samson-Pharma |
5,2 |
0,9% |
24% |
37 |
|
14 |
Ladushka |
4,8 |
0,8% |
12% |
225 |
|
15 |
Melodia zdorovya |
4,5 |
0,7% |
21% |
488 |
|
|
TOP-15 |
148,3 |
24,6% |
13,7% |
8 286 |